Charlotte Gerd Hannibal (Charlotte G Hannibal)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Sentinel Lymph Node

Top Venues

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Louise Baandrup, Charlotte Gerd Hannibal, Rasmus Hertzum-Larsen, Susanne K Kjær
Biopsy-verified vulvar lichen sclerosus: Incidence trends 1997-2022 and increased risk of vulvar squamous precancer and squamous cell carcinoma. International journal of cancer (2024)
Alberte Hjorth Duus, Charlotte Gerd Hannibal, Louise Baandrup, Guoqiao Zheng, Michael Galanakis, Thomas Maltesen, Rasmus Hertzum-Larsen, Lina S Mørch, Susanne K Kjær
Prediagnostic use of menopausal hormone therapy and long-term survival of localized epithelial ovarian cancer: The Extreme study. International journal of cancer 155 (1) (2024)
Louise Baandrup, Charlotte Gerd Hannibal, Rasmus Hertzum-Larsen, Susanne K Kjær
Biopsy-verified vulvar lichen sclerosus: Incidence trends 1997-2022 and increased risk of vulvar squamous precancer and squamous cell carcinoma. International journal of cancer 155 (3) (2024)
Alberte Hjorth Duus, Charlotte Gerd Hannibal, Louise Baandrup, Guoqiao Zheng, Michael Galanakis, Thomas Maltesen, Rasmus Hertzum-Larsen, Lina S Mørch, Susanne K Kjær
Prediagnostic use of menopausal hormone therapy and long-term survival of localized epithelial ovarian cancer: The Extreme study. International journal of cancer (2024)
Emma L Kaderly Rasmussen, Charlotte Gerd Hannibal, Rasmus Hertzum-Larsen, Susanne K Kjær, Louise Baandrup
Biopsy-verified vulvar lichen sclerosus and the risk of non-vulvar cancer: A nationwide cohort study. International journal of cancer (2024)
Charlotte Gerd Hannibal, Louise Baandrup, Rasmus Hertzum-Larsen, Russell Vang, Robert J Kurman, Kirsten Frederiksen, Susanne Krüger Kjaer
Risk of nonovarian cancer in a nationwide-based study of nearly 5000 women with borderline ovarian tumors in Denmark. International journal of cancer (2022)